| 引用本文:莫旭威 王 彬 李海松 党 进 毛鹏鸣 赵 冰 李本志.癃清片对慢性前列腺炎（湿热瘀阻证）伴勃起功能障碍的疗效观察[J].世界中医药,2014,9(09):. |
|
| 癃清片对慢性前列腺炎（湿热瘀阻证）伴勃起功能障碍的疗效观察 |
| Observation on Effect of Longqing Tablets in Treating Damp-Heat Stasis Obstruction Patten of Chronic Prostatitis Accompanying Erectile Dysfunction |
| 投稿时间：2013-09-23 |
| DOI：10.3969/j.issn.1673-7202.2014.09.016 |
| 中文关键词: 慢性前列腺炎 勃起功能障碍 癃清片 湿热瘀阻证 |
| English Keywords:Chronic prostatitis Erectile dysfunction Longqing tables Damp-heat stasis obstuction. |
| 基金项目: |
|
| 摘要点击次数: 1283 |
| 全文下载次数: 1461 |
| 中文摘要: |
| 目的：观察癃清片对慢性前列腺炎（湿热瘀阻证）伴勃起功能障碍（Erectile Dysfunction，ED）的治疗效果。方法：108例慢性前列腺炎伴发ED患者，治疗前行美国国立卫生院慢性前列腺炎症状评分（NIH-CPSI）及国际勃起功能指数问卷5（IIEF-5）评分。将108例患者随机分为对照组（54例）、治疗组（54例）。对照组使用盐酸特拉唑嗪片（马沙尼），口服，2 mg/次，睡前1次，连续治疗8周。治疗组使用癃清片，口服，6片/次，2次/d，连续治疗8周。结果：治疗8周后，对照组NIH-CPSI评分（13.0±5.5）分，较治疗前（21.3±2.2）分，差异有统计学意义（P<0.05）；IIEF-5评分（12.4±3.4）分，较治疗前（13.5±3.4）分，有所增加但差异无统计学意义（P>0.05）；治疗组NIH-CPSI评分（12.4±5.4）分，IIEF-5评分（16.2±4.3）分，与治疗前比较，差异有统计学意义（P<0.05）。对照组ED总有效率为32.65%，治疗组ED总有效率为68.63%，其差异有统计学意义(P<0.01)。结论：癃清片治疗慢性前列腺炎（湿热瘀阻证）伴发ED，既可明显改善慢性前列腺炎的症状，同时，对伴发的ED也有较好的疗效，值得在临床上推广使用。 |
| English Summary: |
| To observe the therapeutic effect of Longqing tablets in treating chronic prostatitis (damp-heat stasis obstruction pattern) accompanying erectile dysfunction. Methods： One hundred and eight patients with chronic prostatitis accompanying ED were given the U.S. National Institutes of Health chronic prostatitis symptom score (NIH-CPSI) and the International Index of Erectile Function questionnaire 5 (IIEF-5) score before treatment. All the patients were randomly divided into control group (n=54), the treatment group (n=54). Control group applied oral administration of terazosin hydrochloride tablets (semaxanib), 2 mg per time before bedtime consecutively for 8 weeks. Treatment group applied oral administration of Longqing tablets, 6 pills per time, 2 times a day for 8 weeks. Results： After 8 weeks of treatment, NIH-CPSI score of patients in the control group was 13.0 ± 5.5 points, which was significantly improved compared with that before treatment (21.3 ± 2.2 points) (P<0.05); IIEF-5 score was 12.4 ± 3.4 points which showed no significant improvement compared with that before treatment (13.5 ± 3.4 points), (P>0.05); NIH-CPSI score of patients in the treatment group was 12.4 ± 5.4 points, and IIEF-5 score was 16.2 ± 4.3points, both of which showed significant improvement compared with what it was before the treatment (P<0.05). The total effective rate for ED of the control group was 32.65%, and that of the treatment group was 68.63%, and the difference between the two groups was significant (P<0.01). Conclusion： Application of Longqing tablets in treating chronic prostatitis (heat stasis) associated with ED can significantly improve symptoms of chronic prostatitis, and meanwhile shows good effect ED, hence it is worth being generalized in clinical practice. |
| 查看全文 查看/发表评论 下载PDF阅读器 |
